Skip to content

Legend Biotech

US · LEGN #2374 by market cap Listed 2020
15.25 -0.85 -5.28%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Legend Biotech

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Bridgewater, NJ.

Founded
2015
CEO
Dr. Ying Huang, PhD
Employees
2,900
Headquarters
Bridgewater, New Jersey, United States of America
Fiscal year end
12-31
Website
legendbiotech.com

Company profile

Exchange
US
Symbol
LEGN
Market-cap rank
#2374
Listing date
2020-06-05
Market cap
2.96B
Float cap
1.39B
Shares out
193.97M
Float shares
91.01M

Sectors & themes

Biotechnology China Concept Stocks Fractional Shares JP

Browse all sectors & themes

Quote time 2026-11-20 20:02:40 · For reference only, not investment advice and not tailored to your situation.

Legend Biotech discussion 0 comments

Add a comment